Artri King Reforzado con Ortiga Omega 3 Tablets — Class I drug recall D-1157-2022
Completed recall by Walmart Inc, reported 2022-06-22, distributed nationwide. Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA ap
| Recall number | D-1157-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Walmart Inc, Bentonville, AR, United States |
| Recall initiated | 2022-05-24 |
| Classified | 2022-06-24 |
| Reported by FDA | 2022-06-22 |
| Distributed | Nationwide (US) |
| Quantity | 1,308 bottles |
| Reason classes | undeclared allergen, unapproved product |
| Lot numbers | LTARTKNGOMG30720 |
Product
Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, 100-count bottles, Melchor Ocampo No. 55 Local D, Delegacion Xochimilco, C.P. 16800, Mexico, D.F., UPC 7 501031 111190.
Reason for recall
Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain and inflammation.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1157-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.